Sonic Healthcare to boom with $750m US acquisition

Sonic Healthcare to boom with $750m US acquisition

Sonic Healthcare (ASX: SHL) could become one of the world's largest pathology groups after reaching a binding agreement to purchase US company Aurora Diagnostics for US$540 million ($750 million).

If the deal passes the necessary anti-trust approvals, Florida-based Aurora will bring 1,200 staff including 200 pathologists under the Sonic umbrella with 32 anatomical practices in 19 US states.

In the year to 30 September, Aurora notched pro forma revenue of US$310 million ($431 million) and EBITDA of US$59 million ($82 million).

Sonic has also announced a fully underwritten institutional placement to raise $600 million, as well as a non-underwritten share purchase plan to raise up to $100 million from retail investors in Australia and New Zealand.

"The Aurora acquisition is an exciting and seminal step for Sonic Healthcare and we warmly welcome the management, pathologists and staff working in Aurora's outstanding anatomical pathology practices around the US," says Sonic's CEO Dr Colin Goldschmidt.

"The integration of these practices into Sonic's existing US operations, in conjunction with Aurora's management team, will offer Sonic Healthcare USA the scale and critical mass to boost the national promotion of Sonic's unique Medical Leadership model in the US laboratory and pathology markets."

The integration of Aurora will be led by its US CEO Dr. Jerry Hussong, with support from Goldschmidt, Sonic's global chief medical officer Dr Stephen Fairy and Aurora's management team.

Never miss a news update, subscribe here. Follow us on Facebook, LinkedIn, Instagram and Twitter.

Business News Australia

Enjoyed this article?

Don't miss out on the knowledge and insights to be gained from our daily news and features.

Subscribe today to unlock unlimited access to in-depth business coverage, expert analysis, and exclusive content across all devices.

Support independent journalism and stay informed with stories that matter to you.

Subscribe now and get 50% off your first year!

AI-driven Evitat platform creates pathway to a more sustainable building and renovation industry
Partner Content
Evitat, an AI-driven data platform, is empowering design and build professionals in the...
Evitat
Advertisement

Related Stories

ASX biotech minnow Hexima raising $4m to buy and become autonomous intelligence company RealThing

ASX biotech minnow Hexima raising $4m to buy and become autonomous intelligence company RealThing

More than two years after losing 87 per cent of its value in a sing...

South Australian expansion lifts revenue for distracted driver detection tech scale-up Acusensus

South Australian expansion lifts revenue for distracted driver detection tech scale-up Acusensus

Distracted driver detection technology company Acusensus (ASX: ACE)...

Would you pay to quit TikTok and Instagram? You’d be surprised how many would

Would you pay to quit TikTok and Instagram? You’d be surprised how many would

Social media is a problem for economists. They don’t know how...

JET Charge rolls out Australia's largest EV dealer charging network with Toyota

JET Charge rolls out Australia's largest EV dealer charging network with Toyota

Melbourne-based JET Charge has announced the successful supply and ...